> Altana of Melville, New York, has acquired the prescription dermatology business of GlaxoSmithKline Consumer Healthcare. Report
> BioDelivery Sciences International has priced an offering of 4.4 million shares at $2 each. Release
> NeoPharm said a reformulated version of its paclitaxel cancer drug demonstrated fewer side effects. Story
> Shareholders of InKine and Salix Pharmaceuticals have endorsed the merger of the two companies. Release
> Progenics Pharmaceuticals of Scottsdale, Arizona, has hit its target enrollment for a second Phase III trial of methylnaltrexone for the treatment of opioid-induced constipation in patients with advanced medical illness. Release
> InSite Vision has completed enrollment in a Phase III trial of AzaSite for the treatment of bacterial conjunctivitis. Release
And Finally… The governor of California terminated a bill that would have set up a Web site steering people to lower-cost Canadian, British and Irish medicine. In his veto, Schwarzenegger said he was worried that it was illegal, fraught with liability and dangerous for consumers. Article